jahresbericht 2012 - Biologische Psychiatrie - Medizinische ...

82fraction derived from transthoracic echocardiography. European Heart Journal –Cardiovascular Imaging 13 (2): 181-186 (IF: 2.317)82. Piralic-Spitzl S, Münker-Kramer E (2012) MigrantInnen in der psychiatrischen undklinisch psychologischen Behandlung und Begutachtung – Die Rolle der Folgenpsychischer Traumatisierung. Psychologie in Österreich 1: 48-54 (IF: 0)83. Pjrek E, Frey R, Naderi-Heiden A, Strnad A, Kowarik A, Kasper S, Winkler D (2012)Actigraphic measurements in opioid detoxification with methadone or buprenorphine.Journal of Clinical Psychopharmacology 32 (1): 75-82 (IF: 4.098)84. Praschak-Rieder N, Willeit M (2012) Imaging of seasonal affective disorder andseasonality effects on serotonin and dopamine function in the human brain. CurrentTopics in Behavioural Neuroscience 11: 149-167 (IF: 0)85. Riederer F, Marti M, Luechinger R, Lanzenberger R, von Meyenburg JV, GantenbeinAR, Pirrotta R, Gaul C, Kollias S, Sándor PS (2012) Grey matter changes associatedwith medication-overuse headache: Correlations with disease related disability andanxiety. World Journal of Biological Psychiatry 13 (7): 517-25 (IF: 2.385)86. Rivera M, Cohen-Woods S, Kapur K, Breen G, Ng MY, Butler AW, Craddock N, GillM, Korszun A, Maier W, Mors O, Owen MJ, Preisig M, Bergmann S, Tozzi F, Rice J,Rietschel M, Rucker J, Schosser A, Aitchison KJ, Uher R, Craig IW, Lewis CM,Farmer AE, McGuffin P (2012) Depressive disorder moderates the effect oft he FTOgene on body mass index. Molecular Psychiatry 17 (6): 604-611 (IF: 13.668)87. Sachs G, Moser E, Katschnig H, Gur RC, Gur RE, Erfurth A (2012) No amygdalaattenuation in schizophrenic patients treated with atypical antipsychotics. PsychiatryResearch - Neuroimaging Section 202 (2): 168-171 (IF: 2.964)88. Sachs G, Winklbaur B, Jagsch R, Lasser I, Kryspin-Exner I, Frommann N, Wölwer W(2012) Training of affect recognition (TAR) in schizophrenia-Impact on functionaloutcome. Schizophrenia Research 138 (2-3): 262-267 (IF: 4.748)89. Saletu-Zyhlarz GM (2012) Schlafstörungen aus psychiatrischer Sicht. Neuro 3: 42-45(IF: 0)90. Saulin A, Savli M, Lanzenberger R (2012) Serotonin and molecular neuroimaging inhumans using PET. Amino Acids 42 (6): 2039-2057 (IF: 3.248)91. Savli M, Bauer A, Mitterhauser M, Ding YS, Hahn A, Kroll T, Neumeister A, HäuslerD, Ungersböck J, Henry S, Attaripour Isfahani A, Rattay F, Wadsak W, Kasper S,Lanzenberger R (2012) Normative database of the serotonergic system in healthysubjects using multi-tracer PET. NeuroImage 63 (1): 447-459 (IF: 5.895)92. Schläpfer T, Agren H, Monteleone P, Gasto C, Pitchot W, Rouillon F, Nutt D, Kasper S(2012) The hidden third: improving outcome in treatment resistant depression. Journalof Psychopharmacology 26 (5): 587-602 (IF: 3.036)93. Schomerus G, Schwahn C, Holzinger A, Corrigan PW, Grabe HJ, Carta MG,Angermeyer MC (2012) Evolution of public attitudes about mental illness: a systematicreview and meta-analysis. Acta Psychiatrica Scandinavica 125 (6): 440-452 (IF: 4.220)